Insulin-Like Growth Factors in the Pathogenesis of Neurological Diseases in Children
Insulin-like growth factors play a key role for neuronal growth, differentiation, the survival of neurons and synaptic formation. The action of IGF-1 is most pronounced in the developing brain. In this paper we will try to give an answer to the following questions: Why are studies in children import...
Main Author: | |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2017-09-01
|
Series: | International Journal of Molecular Sciences |
Subjects: | |
Online Access: | https://www.mdpi.com/1422-0067/18/10/2056 |
id |
doaj-3dced45fa6bf4227a0cb368caae46139 |
---|---|
record_format |
Article |
spelling |
doaj-3dced45fa6bf4227a0cb368caae461392020-11-24T20:47:59ZengMDPI AGInternational Journal of Molecular Sciences1422-00672017-09-011810205610.3390/ijms18102056ijms18102056Insulin-Like Growth Factors in the Pathogenesis of Neurological Diseases in ChildrenRaili Riikonen0Child Neurology, Children’s Hospital, University of Eastern Finland and Kuopio University Hospital, P.O. Box 1627, FI-70211 Kuopio, FinlandInsulin-like growth factors play a key role for neuronal growth, differentiation, the survival of neurons and synaptic formation. The action of IGF-1 is most pronounced in the developing brain. In this paper we will try to give an answer to the following questions: Why are studies in children important? What clinical studies in neonatal asphyxia, infantile spasms, progressive encephalopathy–hypsarrhythmia–optical atrophy (PEHO) syndrome, infantile ceroid lipofuscinosis (INCL), autistic spectrum disorders (ASD) and subacute sclerosing encephalopathy (SSPE) have been carried out? What are IGF-based therapeutic strategies? What are the therapeutic approaches? We conclude that there are now great hopes for the therapeutic use of IGF-1 for some neurological disorders (particularly ASD).https://www.mdpi.com/1422-0067/18/10/2056insulin-like growth factorpathogenesisneonatesneurodevelopmental disordersneurodegenerationneuroprotectionchildren |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Raili Riikonen |
spellingShingle |
Raili Riikonen Insulin-Like Growth Factors in the Pathogenesis of Neurological Diseases in Children International Journal of Molecular Sciences insulin-like growth factor pathogenesis neonates neurodevelopmental disorders neurodegeneration neuroprotection children |
author_facet |
Raili Riikonen |
author_sort |
Raili Riikonen |
title |
Insulin-Like Growth Factors in the Pathogenesis of Neurological Diseases in Children |
title_short |
Insulin-Like Growth Factors in the Pathogenesis of Neurological Diseases in Children |
title_full |
Insulin-Like Growth Factors in the Pathogenesis of Neurological Diseases in Children |
title_fullStr |
Insulin-Like Growth Factors in the Pathogenesis of Neurological Diseases in Children |
title_full_unstemmed |
Insulin-Like Growth Factors in the Pathogenesis of Neurological Diseases in Children |
title_sort |
insulin-like growth factors in the pathogenesis of neurological diseases in children |
publisher |
MDPI AG |
series |
International Journal of Molecular Sciences |
issn |
1422-0067 |
publishDate |
2017-09-01 |
description |
Insulin-like growth factors play a key role for neuronal growth, differentiation, the survival of neurons and synaptic formation. The action of IGF-1 is most pronounced in the developing brain. In this paper we will try to give an answer to the following questions: Why are studies in children important? What clinical studies in neonatal asphyxia, infantile spasms, progressive encephalopathy–hypsarrhythmia–optical atrophy (PEHO) syndrome, infantile ceroid lipofuscinosis (INCL), autistic spectrum disorders (ASD) and subacute sclerosing encephalopathy (SSPE) have been carried out? What are IGF-based therapeutic strategies? What are the therapeutic approaches? We conclude that there are now great hopes for the therapeutic use of IGF-1 for some neurological disorders (particularly ASD). |
topic |
insulin-like growth factor pathogenesis neonates neurodevelopmental disorders neurodegeneration neuroprotection children |
url |
https://www.mdpi.com/1422-0067/18/10/2056 |
work_keys_str_mv |
AT railiriikonen insulinlikegrowthfactorsinthepathogenesisofneurologicaldiseasesinchildren |
_version_ |
1716809361902272512 |